Congress funds research into a condition hitting Black women hardest
S. 2531 — Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025 · Filed by Angela Alsobrooks (D-MD) · 4 cosponsors · Introduced Jul 30, 2025 · Hearing held
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the Secretary of Health and Human Services to fund research on early detection of uterine fibroids and to award grants to states for screening programs, patient navigation services, and public awareness campaigns. It also funds research into pain management disparities in fibroid treatment and related intrauterine conditions, with biennial reporting to Congress on findings.
Why we flagged it
The bill is a straightforward public health measure authorizing federal research funding and state grant programs to improve early detection and treatment of uterine fibroids, a common gynecological condition.
What the text implies
- By funding research into pain management disparities, the bill implicitly acknowledges and addresses documented racial disparities in fibroid care and pain treatment, which may drive systemic improvements in how gynecological pain is managed across populations.
- State grant programs may create new infrastructure for advanced gynecological imaging and patient navigation that could benefit broader women's health screening beyond fibroids.
The full analysis lists 3 implications of this text.
Who stands to gain
medical imaging equipment manufacturers; healthcare systems and hospitals; research institutions and universities